COVID-19 Funding Opportunities
Post-acute sequelae of SARS-CoV-2 (PASC), also referred to as long
COVID, is defined as signs, symptoms, and conditions that continue
or develop after initial COVID-19 infection. Such signs, symptoms,
and conditions linger or develop 4 or more weeks following the
acute infection, and can last weeks, months, and even years. Furthermore,
PASC-related symptoms are wide ranging, and can have cardiopulmonary,
gastrointestinal, dermatologic, endocrine, psychiatric and/or neurological
manifestations, including sensory dysfunction and cognitive-communication
difficulties. Further research is critical to understand the symptomatology,
pathogenesis, and underlying mechanisms of PASC. NIDCD invites
applications for research on PASC in relation to NIDCD’s scientific
programs of hearing, balance, taste, smell, voice, speech and language.
When appropriate, NIDCD encourages multi-disciplinary approaches
to move the research beyond in vitro and animal models.
Deadline:
Opportunity expires January 30, 2027. See full solicitation (linked above) for more details.
NOSI: Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
NIH Institutes, Centers, and Offices participating in the Social, Behavioral, and Economic Impacts of COVID-19 in Vulnerable and Health Disparity Populations initiative are issuing this Notice of Special Interest (NOSI) to highlight interest in research to strengthen the understanding and response to the Coronavirus Disease 2019 (COVID-19) pandemic and help us prepare more effectively for future public health emergencies. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, there are additional urgent public health needs, particularly in populations who experience health disparities and in vulnerable populations. The purpose of this Notice is to 1) emphasize the roles and impacts of interventions, particularly those under the umbrella of digital health, as well as community-engaged and multi-level interventions in healthcare settings to address access, reach, delivery, engagement, effectiveness, scalability, and sustainability of services that are utilized during and following the pandemic, and 2) encourage the leveraging of existing large-scale data sources with broad population coverage to improve prediction of various mitigation efforts (including vaccinations, masking, and physical distancing to inform the public health response) on transmission reduction and on social and economic impacts, and assess the downstream health and healthcare access effects, with an emphasis on underserved and vulnerable populations. Additionally, the use of large-scale data sources to study the indirect health impacts of the pandemic and subsequent social and economic changes is needed to understand the costs and benefits of various COVID-19 mitigation strategies.
Deadline: Opportunity expires September 8, 2024. See full solicitation (linked above) for more details.
NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
The purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. This Notice is a reissuance of NOT-DA-20-084. NIDA is interested in receiving research applications focusing on individuals who smoke or vape either marijuana and/or tobacco to determine: 1) the risk of contracting a COVID-19 infection, 2) the effects on asymptomatic COVID-19 infected persons, and 3) the course of the COVID-19 infection.
Deadline:
Opportunity expires September 8, 2024.
See full solicitation (linked above) for more details.
NOSI: Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
NIDA is interested in receiving research applications focusing on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19. Research areas include the following:
1) The risks that smoking and/or vaping tobacco, marijuana,
cocaine, and/or methamphetamine may have on acquiring the SARS-CoV2
infection in individuals with HIV.
2) The medical consequences, co-morbidity, and complications of
SARS-CoV2 infection affecting cardiovascular, respiratory,
renal, gastrointestinal, hematological, immunological, CNS and
PNS systems in HIV individuals who smoke and/or vape tobacco,
marijuana, cocaine, and/or methamphetamine.
3) Defining mechanisms by which substance use and HIV interact
to increase susceptibility to severe COVID-19 affecting cardiovascular,
respiratory, renal, gastrointestinal, hematological, immunological,
CNS and PNS morbidity.
4) Utilization of large database- Electronic Health Records – strategies for
retrospective and platform based prospective studies, cross analyses,
and real-time health delivery and critical health-related decisions
in emergency medicine settings.
Investigators are encouraged to make use of existing data sets and resources.
Investigators are encouraged to make use of existing data sets and resources.
Deadline:
Opportunity expires
September 8, 2024.
See full solicitation (linked above) for more details.
NOSI: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
NIDA is interested in receiving research applications focusing on
studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs
syndemic. This NOSI encourages, but is not limited to, research
applications in these areas:
1) Long-term neurocognitive ef
fects of HIV/COVID-19/SUDs. Basic science studies to explore changes
in neuroanatomy, neurophysiology, biochemistry, learning and
behavior.
2) Clinical studies to evaluate cognitive, behavioral, neuropsychiatric,
neuro-therapeutic outcomes, etc. Staging and categorizing of
cognitive dysfunction. Differentiation between HAND and COVID-19
neurocognitive impairment in individuals with and without SUDs.
Validation of neurocognitive scales for HAND and COVI-19 neurocognitive
impairment.
3) N
eurocognitive studies in individuals with HIV/COVID-19/SUDs classified
by age/gender/race/socioeconomic status/drug of choice use/ART
regime/HCV status/other co-morbidities/criminal justice involvement,
etc.
4) Therapeutic strategies for such neurocognitive dysfunction in
the context of HIV. Effectiveness of NMDA receptor antagonists,
Anticholinergics, B12 supplements, Thiamine, SSRI’s, Benzodiazepines,
Antipsychotics, etc., and its interactions with ART and SUDs.
Cognitive Behavioral Therapy; Mindfulness; Meditation; Transcranial
Magnetic Stimulation and others.
Deadline:
Opportunity expires
September 8, 2024.
See full solicitation (linked above) for more details.
NOSI: COVID-19 Pandemic Mental Health Research
NIMH is issuing this Notice to highlight interest in basic, translational, intervention and services research relevant to the COVID-19 pandemic. NIMH is especially interested in research to provide an evidence base to understand how mental illness contributes to COVID-19 risk and mortality, how incident mental illness develops with COVID-19, and the development of scalable interventions to meet the public mental health needs during and resulting from the pandemic both specifically related to the virus but also at a broader population level that is impacted by stress, disruptions, and loss of lives in the pandemic. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH. Research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting and worsening health disparities.Deadline: Opportunity expires January 8, 2025. See full solicitation (linked above) for more details.
NOSI: Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy
This Notice of Special Interest (NOSI) aims to accelerate a comprehensive
understanding of the mechanisms of COVID-19-Associated Coagulopathy
(CAC) which are provoked by vascular endothelial cell injury, hyperimmune
responses, and hypercoagulability at genomic, molecular, and cellular
levels. Knowledge obtained from such studies may be applied
to the future design of early diagnostics and effective treatment
for high-risk patients as well as enable CAC research findings
to be applied to on-going COVID-19 clinical trials. Applicants
are encouraged to establish collaborations among researchers with
a multi-disciplinary background, such as cell biology, molecular
biology, immunology, hematology, virology, systems biology, multi-omics,
and data science. Applications must be submitted using
PA-20-185 or its reissue.
Deadline:
Opportunity expires
July 6, 2025.
See full solicitation (linked above) for more details.
NOSI: Pediatric COVID-19 and Respiratory Viral Co-infection
This NOSI is intended to support projects that will employ existing
and new clinical trial cohorts/observational cohorts to screen
for co-infection, phenotype and collect biospecimens to answer
some of the questions below and to encourage investigator-initiated
applications for basic, translational and human subject research
(not clinical trials) in this space.
Deadline:
Opportunity expires September 8, 2025.
See full solicitation (linked above) for more details.
NOSI: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in COVID-19
The National Institute of Dental and Craniofacial Research (NIDCR) is reissuing this Notice of Special Interest (NOSI) to encourage research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19). As the pandemic continues to evolve and new viral variants continue to emerge the need to fill knowledge gaps and for a better understanding of SARS-CoV-2 remain. A major unmet clinical need has arisen to block the transmission chain, prevent frequent breakthrough infections, and achieve high levels of durable protection against severe disease, no less prevent post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID). NIDCR is positioned to address COVID-19 research knowledge gaps unique to our mission, as well as to facilitate broad and rapid dissemination of research findings. Outcomes from this NOSI are expected to strengthen the knowledge base of COVID-19 disease mechanisms and presentations in the oral cavity.
Deadline
:
Opportunity expires
May 8, 2026.
See full solicitation (linked above) for more details.
National Science Foundation (NSF) Funding Opportunities:
Dear Colleague Letter: NSF and Social Science Research Council Partnership to Advance Scientific Knowledge about the Impact of Public Health Guidance
To help focus research on what we know and can learn about how
individuals, groups and institutions make decisions related or
in response to public health issues, NSF is partnering with the
SSRC in a collaboration called "Advance Scientific Knowledge
about the Impact of Public Health Guidance." Drawing on their
complementary strengths, these two funders intend to jointly
fund proposals that advance scientific knowledge about the impact
of public health guidance. The public interest in this endeavor
is self-evident in the time of COVID-19, but even after this
pandemic is successfully managed, there will continue to be a
public interest and societal need, not only in the U.S. but across
the globe, for research to clarify what contributes to the impact
of public health guidance. To designate the proposal as
being related to this research topic and submitted in response
to this DCL, proposals must include "NSF-SSRC:" at the beginning
of the proposal title.
Pulitzer Center: COVID-19, Vaccines, and Global Health Inequities
The Pulitzer Center is seeking applications for enterprise
and underreported stories about COVID-19 inequities and other
U.S. and global health system failures. The Center is interested
in systemic barriers to all sorts of care, including, but
not limited to, COVID-19 vaccines and treatment, and stories
about misinformation and politicization that impede improved
access to care and preparation for future health crises.
This opportunity is open to all newsrooms and independent
journalists in the United States and abroad. Applications
must include
a description of the proposed project in no more than 250
words; a
preliminary budget estimate, including a basic breakdown
of costs; and a
compelling distribution plan.
Deadline: Full proposals accepted anytime
Amazon Web Services Diagnostic Development Initiative (DDI)
This initiative provides support for innovation in rapid
and accurate patient testing for 2019 novel coronavirus (COVID-19),
and other diagnostic solutions to mitigate future outbreaks.
Although vaccine and treatment development research is generally
funded by private foundations and government agencies, fast
and reliable diagnostic techniques are slow to be developed.
Accurate testing and diagnosis
at point-of-care or regional locations for patients with COVID-19
is critical to early intervention and treatment. AWS is offering
technical support and providing AWS promotional credits to
support the use of AWS services to advance diagnostic research
for selected institutions and companies.
Deadline:
June 30, 2024; November 15, 2024
Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health
Pioneering Ideas: Exploring the Future to Build a Culture of
Health seeks proposals that are primed to influence health
equity in the future. We are interested in ideas that address
any of these four areas of focus: Future of Evidence; Future
of Social Interaction; Future of Food; Future of Work. Additionally,
we welcome ideas that might fall outside of these four focus
areas, but which offer unique approaches to advancing health
equity and our progress toward a Culture of Health. We want
to hear from scientists, anthropologists, artists, urban planners,
community leaders—anyone, anywhere who has a new or unconventional
idea that could alter the trajectory of health, and improve
health equity and well-being for generations to come. The changes
we seek require diverse perspectives and cannot be accomplished
by any one person, organization or sector. While this
call for proposals is focused on broader and longer-term societal
trends and shifts that were evolving prior to the COVID-19
outbreak, we recognize the unique circumstances and learning
created by the COVID-19 pandemic may inform your response.
It is at your discretion whether you propose a project related
to the pandemic directly or indirectly.
Deadline:
Full proposals accepted anytime
Funding Portals, Search Engines, and Other Resources:
Pivot at West Virginia University
Pivot focuses on what matters most to you—the ability to identify and connect with funding opportunities and other researchers, locally and globally. It combines the most comprehensive, editorially-maintained database of funding opportunities worth an estimated $33 billion with a unique database of 3 million scholar profiles—and growing. Access to Pivot is limited to authenticated users only; you must have an email address that ends in one of the following ways: mail.wvu.edu, mix.wvu.edu, or hsc.wvu.edu. To stay updated on COVID-19 funding information, we recommend saving a “COVID-19” search. Results will be emailed to you weekly.Grant Station
Funding opportunities for nonprofits in the area of COVID-19, updated each business day and listed by deadline date. Use Ctrl + F on your keyboard to search funding opportunities or jump to a particular section of interest by using the links.Johns Hopkins University COVID-19 Funding Opportunities
The JHU Office of the Vice Provost for Research (VPR) has compiled several funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
InfoEd Global is proud to be able to share this library
of COVID-19 funding opportunities and resources with our
colleagues in the research realm and the broader community
at large.
COSSA COVID-19 Social Science Resources
COSSA (Consortium of Social Science Associations) is compiling
a list of resources for social scientists and stakeholders
related to the COVID-19 pandemic. The list includes guidance
from federal science agencies, collections of publicly available
peer-reviewed research related to the crisis, resources from
COSSA member associations, and more. There are a number of
new databases for researchers wishing to amplify their work
that may have relevance to the current crisis, including
the COVID-19 Open Research Dataset, supported by the Allen
Institute for AI, and a grassroots effort on GitHub to compile
new social science research related to COVID-19.
NIH/NCBI/NLM’s LitCovid Literature Hub
LitCovid is a curated literature hub for tracking up-to-date scientific information about the Coronavirus. It is the most comprehensive resource on the subject, providing central access to a growing number of relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.Open-Access Data and Computational Resources to Address COVID-19
COVID-19 open-access data and computational resources are being provided by federal agencies, including NIH, public consortia, and private entities. These resources are freely available to researchers, and this page will be updated as more information becomes available.USDA COVID-19 Federal Rural Resource Guide
The COVID-19 Federal Rural Resource Guide is a helpful resource published by the U.S. Department of Agriculture unveiled by the USDA for rural communities looking for federal funding and partnership opportunities to help address COVID-19. This resource matrix organizes funding opportunities identified in the CARES Act and other federal resources that can help support rural America. Opportunities are categorized by customer and assistance type.WV-Specific Resources: